Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019209 (
hepatomegaly
)
5,798
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report a new type of fatal mitochondrial disorder caused by selective deficiency of mitochondrial
ATP synthase
(
ATPase
). A hypotrophic newborn from a consanguineous marriage presented severe lactic acidosis, cardiomegaly and
hepatomegaly
and died from heart failure after 2 days. The activity of oligomycin-sensitive
ATPase
was only 31-34% of the control, both in muscle and heart, but the activities of cytochrome c oxidase, citrate synthase and pyruvate dehydrogenase were normal. Electrophoretic and western blot analysis revealed selective reduction of
ATPase
complex but normal levels of the respiratory chain complexes I, III and IV. The same selective deficiency of
ATPase
was found in cultured skin fibroblasts which showed similar decreases in
ATPase
content,
ATPase
hydrolytic activity and level of substrate-dependent ATP synthesis (20-25, 18 and 29-33% of the control, respectively). Pulse-chase labelling of patient fibroblasts revealed low incorporation of [(35)S]methionine into assembled
ATPase
complexes, but increased incorporation into immunoprecipitated
ATPase
subunit beta, which had a very short half-life. In contrast, no difference was found in the size and subunit composition of the assembled and newly produced
ATPase
complex. Transmitochondrial cybrids prepared from enucleated fibroblasts of the patient and rho degrees cells derived from 143B. TK(-)human osteosarcoma cells fully restored the
ATPase
activity, ATP synthesis and
ATPase
content, when compared with control cybrids. Likewise, the pattern of [(35)S]methionine labelling of
ATPase
was found to be normal in patient cybrids. We conclude that the generalized deficiency of mitochondrial ATPase described is of nuclear origin and is caused by altered biosynthesis of the enzyme.
...
PMID:A novel deficiency of mitochondrial ATPase of nuclear origin. 1048 64
We present clinical and laboratory data from 14 cases with an isolated deficiency of the mitochondrial
ATP synthase
(7-30% of control) caused by nuclear genetic defects. A quantitative decrease of the
ATP synthase
complex was documented by Blue-Native electrophoresis and Western blotting and was supported by the diminished activity of oligomycin/aurovertin-sensitive ATP hydrolysis in fibroblasts (10 cases), muscle (6 of 7 cases), and liver (one case). All patients had neonatal onset and elevated plasma lactate levels. In 12 patients investigated 3-methyl-glutaconic aciduria was detected. Seven patients died, mostly within the first weeks of life and surviving patients showed psychomotor and various degrees of mental retardation. Eleven patients had hypertrophic cardiomyopathy; other clinical signs included hypotonia,
hepatomegaly
, facial dysmorphism and microcephaly. This phenotype markedly differs from the severe central nervous system changes of
ATP synthase
disorders caused by mitochondrial DNA mutations of the ATP6 gene presenting mostly as NARP and MILS.
...
PMID:Deficiency of mitochondrial ATP synthase of nuclear genetic origin. 1705 6